“Adjuvant Nivolumab in Resected Oesophageal or Gastroesophageal Junction Cancer Following Neoadjuvant Chemoradiotherapy: Slove-Nian Real-World Data”. 2026. Radiology and Oncology 60 (2): 288-93. https://www.radioloncol.com/index.php/ro/article/view/4731.